A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Clinical trial NCT00884312 · COMPLETED

Trial details

NCT number: NCT00884312
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Solid Tumors

Start date: 2009-04-09
Primary completion: 2017-05-17
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.